Abraxane induced life-threatening toxicities with metastatic breast cancer and hepatic insufficiency.
Villano
J Lee
JL
Department of Medicine, Section of Hematology/Oncology and Cancer Center, University of Illinois, Chicago, USA.
Mehta
Divyesh
D
Radhakrishnan
Latha
L
D000068196:Albumin-Bound Paclitaxel; D000418:Albumins / Q000009:adverse effects / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D001663:Bilirubin / Q000378:metabolism; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D008875:Middle Aged; D052016:Mucositis / Q000139:chemically induced; D009325:Nausea; D009503:Neutropenia / Q000139:chemically induced; D017239:Paclitaxel / Q000009:adverse effects* / Q000627:therapeutic use
D000068196:Albumin-Bound Paclitaxel; D000418:Albumins; D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel; D001663:Bilirubin